marine link image
Register now for the Port of the Future Conference • 2 Days, 50 Ports • Houston/Galveston area, TX • April 12–14, 2027

Global Ship Lease Report Q1 Financials

May 3, 2017

The containership charter owner Global Ship Lease (GSL) has reported first-quarter net income of $6.8 million. Its revenue stood at $39.6 mln for the Quarter.

 
Ian Webber, Chief Executive Officer of Global Ship Lease, stated, "During the first quarter of 2017, we continued to execute our core strategy, maximizing the value of our long-term time charters with high-quality counterparties, maintaining high levels of vessel utilization and closely controlling costs. Our success in this regard has enabled us to continue generating strong, stable cashflows."
 
The fleet generated operating revenues from fixed-rate time charters of $39.6 million in the three months ended March 31, 2017, down $3.0 million or 7.0% on operating revenues of $42.6 million for the comparative quarter in 2016.
 
At March 31, 2017, Global Ship Lease owned 18 vessels with a total capacity of 82,312 TEU and an average age, weighted by TEU capacity, of 12.3 years. All vessels are currently fixed on time charters, 15 with CMA CGM. The average remaining term of the charters is 3.4 years or 3.7 years on a weighted basis.
 

Logistics News

Ukraine Explores Using Baltic Ports for Grain Exports

Ukraine Explores Using Baltic Ports for Grain Exports

Few Countries Purchase Russian Wheat After Black Sea Trade Stalls

Few Countries Purchase Russian Wheat After Black Sea Trade Stalls

SGX, European Energy Exchange Offer Baltic Handysize Futures Contracts

SGX, European Energy Exchange Offer Baltic Handysize Futures Contracts

Supply Pressurei in Container Vessel Sector

Supply Pressurei in Container Vessel Sector

Subscribe for Maritime Logistics Professional E‑News

Murmansk, a Russian Arctic port, will start shipping grain using fertiliser equipment
Sources say that Iraq has suspended Iranian flights from Baghdad due to US sanctions threats
Denmark's central banks expects a 4% growth in GDP by 2026, driven by the pharmaceutical industry